Annual D&A
$3.01 M
+$277.00 K+10.14%
31 December 2023
Summary:
Vanda Pharmaceuticals annual depreciation & amortization is currently $3.01 million, with the most recent change of +$277.00 thousand (+10.14%) on 31 December 2023. During the last 3 years, it has risen by +$146.00 thousand (+5.10%). VNDA annual D&A is now -77.79% below its all-time high of $13.55 million, reached on 31 December 2015.VNDA Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$1.97 M
-$1000.00-0.05%
30 September 2024
Summary:
Vanda Pharmaceuticals quarterly depreciation & amortization is currently $1.97 million, with the most recent change of -$1000.00 (-0.05%) on 30 September 2024. Over the past year, it has increased by +$1.39 million (+239.14%). VNDA quarterly D&A is now -54.08% below its all-time high of $4.28 million, reached on 31 March 2015.VNDA Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$7.32 M
+$1.39 M+23.39%
30 September 2024
Summary:
Vanda Pharmaceuticals TTM depreciation & amortization is currently $7.32 million, with the most recent change of +$1.39 million (+23.39%) on 30 September 2024. Over the past year, it has increased by +$4.80 million (+190.93%). VNDA TTM D&A is now -46.02% below its all-time high of $13.55 million, reached on 31 December 2015.VNDA TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VNDA Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.1% | +239.1% | +190.9% |
| 3 y3 years | +5.1% | +177.8% | +156.9% |
| 5 y5 years | +1.8% | +170.9% | +151.5% |
VNDA Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +10.1% | -11.6% | +239.1% | at high | +190.9% |
| 5 y | 5 years | at high | +10.1% | -11.6% | +239.1% | at high | +190.9% |
| alltime | all time | -77.8% | +699.0% | -54.1% | +1925.8% | -46.0% | +6369.5% |
Vanda Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.97 M(-0.1%) | $7.32 M(+23.4%) |
| June 2024 | - | $1.97 M(-11.5%) | $5.93 M(+29.9%) |
| Mar 2024 | - | $2.22 M(+92.1%) | $4.56 M(+51.6%) |
| Dec 2023 | $3.01 M(+10.1%) | $1.16 M(+99.7%) | $3.01 M(+19.7%) |
| Sept 2023 | - | $580.00 K(-3.7%) | $2.52 M(-3.8%) |
| June 2023 | - | $602.00 K(-10.1%) | $2.61 M(-3.3%) |
| Mar 2023 | - | $670.00 K(+1.1%) | $2.70 M(-1.2%) |
| Dec 2022 | $2.73 M(-3.8%) | $663.00 K(-2.2%) | $2.73 M(-1.5%) |
| Sept 2022 | - | $678.00 K(-1.7%) | $2.78 M(-1.1%) |
| June 2022 | - | $690.00 K(-1.7%) | $2.81 M(-0.8%) |
| Mar 2022 | - | $702.00 K(-0.6%) | $2.83 M(-0.5%) |
| Dec 2021 | $2.84 M(-0.8%) | $706.00 K(-0.3%) | $2.84 M(-0.2%) |
| Sept 2021 | - | $708.00 K(-0.6%) | $2.85 M(-0.3%) |
| June 2021 | - | $712.00 K(-0.4%) | $2.86 M(0.0%) |
| Mar 2021 | - | $715.00 K(+0.3%) | $2.86 M(-0.2%) |
| Dec 2020 | $2.86 M(-1.0%) | $713.00 K(-0.7%) | $2.86 M(-0.8%) |
| Sept 2020 | - | $718.00 K(+0.8%) | $2.89 M(-0.3%) |
| June 2020 | - | $712.00 K(-1.2%) | $2.89 M(-0.2%) |
| Mar 2020 | - | $721.00 K(-1.9%) | $2.90 M(+0.3%) |
| Dec 2019 | $2.89 M(-2.2%) | $735.00 K(+1.2%) | $2.89 M(-0.6%) |
| Sept 2019 | - | $726.00 K(+1.0%) | $2.91 M(-0.8%) |
| June 2019 | - | $719.00 K(+1.0%) | $2.93 M(-1.2%) |
| Mar 2019 | - | $712.00 K(-5.3%) | $2.97 M(+0.4%) |
| Dec 2018 | $2.96 M(-0.9%) | $752.00 K(+0.5%) | $2.96 M(-0.6%) |
| Sept 2018 | - | $748.00 K(-0.9%) | $2.98 M(-0.9%) |
| June 2018 | - | $755.00 K(+7.7%) | $3.00 M(+0.7%) |
| Mar 2018 | - | $701.00 K(-9.1%) | $2.98 M(-0.1%) |
| Dec 2017 | $2.98 M(-74.9%) | $771.00 K(-0.4%) | $2.98 M(-35.1%) |
| Sept 2017 | - | $774.00 K(+5.3%) | $4.60 M(-34.2%) |
| June 2017 | - | $735.00 K(+4.4%) | $6.99 M(-25.7%) |
| Mar 2017 | - | $704.00 K(-70.5%) | $9.41 M(-20.7%) |
| Dec 2016 | $11.87 M(-12.4%) | $2.39 M(-24.5%) | $11.87 M(-5.7%) |
| Sept 2016 | - | $3.16 M(+0.1%) | $12.59 M(+0.5%) |
| June 2016 | - | $3.16 M(-0.1%) | $12.53 M(+0.7%) |
| Mar 2016 | - | $3.16 M(+1.8%) | $12.43 M(-8.3%) |
| Dec 2015 | $13.55 M(+386.9%) | $3.10 M(+0.2%) | $13.55 M(+21.9%) |
| Sept 2015 | - | $3.10 M(+1.1%) | $11.12 M(+28.0%) |
| June 2015 | - | $3.06 M(-28.5%) | $8.69 M(+36.2%) |
| Mar 2015 | - | $4.28 M(+539.4%) | $6.38 M(+129.1%) |
| Dec 2014 | $2.78 M | $670.00 K(+0.3%) | $2.78 M(+7.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2014 | - | $668.00 K(-11.6%) | $2.60 M(+7.5%) |
| June 2014 | - | $756.00 K(+9.6%) | $2.42 M(+13.0%) |
| Mar 2014 | - | $690.00 K(+41.4%) | $2.14 M(+11.1%) |
| Dec 2013 | $1.93 M(-9.4%) | $488.00 K(+0.4%) | $1.93 M(+0.3%) |
| Sept 2013 | - | $486.00 K(+1.9%) | $1.92 M(+0.3%) |
| June 2013 | - | $477.00 K(+0.2%) | $1.92 M(+0.6%) |
| Mar 2013 | - | $476.00 K(-1.2%) | $1.90 M(-10.5%) |
| Dec 2012 | $2.13 M(+8.4%) | $482.00 K(+0.2%) | $2.13 M(-3.6%) |
| Sept 2012 | - | $481.00 K(+3.4%) | $2.21 M(-1.9%) |
| June 2012 | - | $465.00 K(-33.6%) | $2.25 M(+1.4%) |
| Mar 2012 | - | $700.00 K(+24.6%) | $2.22 M(+12.9%) |
| Dec 2011 | $1.96 M(+7.3%) | $562.00 K(+7.5%) | $1.96 M(+5.8%) |
| Sept 2011 | - | $523.00 K(+20.8%) | $1.86 M(+3.7%) |
| June 2011 | - | $433.00 K(-2.9%) | $1.79 M(-1.3%) |
| Mar 2011 | - | $446.00 K(-2.0%) | $1.81 M(-0.9%) |
| Dec 2010 | $1.83 M(+28.5%) | $455.00 K(-0.2%) | $1.83 M(-0.9%) |
| Sept 2010 | - | $456.00 K(-0.2%) | $1.85 M(-1.5%) |
| June 2010 | - | $457.00 K(-1.3%) | $1.88 M(+6.3%) |
| Mar 2010 | - | $463.00 K(-1.9%) | $1.77 M(+23.9%) |
| Dec 2009 | $1.43 M(+168.5%) | $472.10 K(-2.4%) | $1.43 M(+31.9%) |
| Sept 2009 | - | $483.90 K(+39.8%) | $1.08 M(+46.0%) |
| June 2009 | - | $346.20 K(+181.9%) | $740.10 K(+39.4%) |
| Mar 2009 | - | $122.80 K(-3.8%) | $531.00 K(+0.0%) |
| Dec 2008 | $530.80 K(-7.1%) | $127.70 K(-10.9%) | $530.80 K(+0.5%) |
| Sept 2008 | - | $143.40 K(+4.6%) | $527.90 K(-1.8%) |
| June 2008 | - | $137.10 K(+11.8%) | $537.60 K(-1.4%) |
| Mar 2008 | - | $122.60 K(-1.8%) | $545.50 K(-4.6%) |
| Dec 2007 | $571.60 K(-0.7%) | $124.80 K(-18.5%) | $571.60 K(-5.8%) |
| Sept 2007 | - | $153.10 K(+5.6%) | $607.00 K(+0.3%) |
| June 2007 | - | $145.00 K(-2.5%) | $605.10 K(+0.2%) |
| Mar 2007 | - | $148.70 K(-7.2%) | $603.90 K(+5.0%) |
| Dec 2006 | $575.40 K(+35.8%) | $160.20 K(+6.0%) | $575.40 K(+10.1%) |
| Sept 2006 | - | $151.20 K(+5.1%) | $522.60 K(+9.4%) |
| June 2006 | - | $143.80 K(+19.6%) | $477.60 K(+10.8%) |
| Mar 2006 | - | $120.20 K(+11.9%) | $430.90 K(+1.7%) |
| Dec 2005 | $423.80 K(+12.5%) | $107.40 K(+1.1%) | $423.80 K(+33.9%) |
| Sept 2005 | - | $106.20 K(+9.4%) | $316.40 K(+50.5%) |
| June 2005 | - | $97.10 K(-14.1%) | $210.20 K(+85.9%) |
| Mar 2005 | - | $113.10 K | $113.10 K |
| Dec 2004 | $376.70 K | - | - |
FAQ
- What is Vanda Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals annual D&A year-on-year change?
- What is Vanda Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals quarterly D&A year-on-year change?
- What is Vanda Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals TTM D&A year-on-year change?
What is Vanda Pharmaceuticals annual depreciation & amortization?
The current annual D&A of VNDA is $3.01 M
What is the all time high annual D&A for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high annual depreciation & amortization is $13.55 M
What is Vanda Pharmaceuticals annual D&A year-on-year change?
Over the past year, VNDA annual depreciation & amortization has changed by +$277.00 K (+10.14%)
What is Vanda Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of VNDA is $1.97 M
What is the all time high quarterly D&A for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high quarterly depreciation & amortization is $4.28 M
What is Vanda Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, VNDA quarterly depreciation & amortization has changed by +$1.39 M (+239.14%)
What is Vanda Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of VNDA is $7.32 M
What is the all time high TTM D&A for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high TTM depreciation & amortization is $13.55 M
What is Vanda Pharmaceuticals TTM D&A year-on-year change?
Over the past year, VNDA TTM depreciation & amortization has changed by +$4.80 M (+190.93%)